
    
      Patients who fit the inclusion criteria will be randomly divided into three groups: TW group
      (TW at dosage of 90 mg/d), ARB group (the control group, valsartan at dosage of 160 mg/d) and
      combined treatment group (TW at dosage of 60 mg/d and valsartan at dosage of 80 mg/d).
    
  